Heng Lin
Impact in
- Immunology top 2%
- interferon and immune responses
- Immune Response and Inflammation
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Peroxisome Proliferator-Activated Receptors 10
- Immunology 29
- interferon and immune responses 14
- Immune Response and Inflammation 10
- Co-authors
- Ching‐Feng Cheng (30 shared papers)Hui‐Chen Ku (4 shared papers)Hong‐Bing Shu (14 shared papers)Ming‐Ming Hu (9 shared papers)Fang Hua (14 shared papers)Hsi-Hsien Chen (20 shared papers)Zhi Chen (13 shared papers)Hsiao‐Fen Li (12 shared papers)
- Journals
- Molecular Pharmacology (6 papers)Journal of Cellular Physiology (6 papers)Proceedings of the National Academy of Sciences (4 papers)International Journal of Molecular Sciences (4 papers)Scientific Reports (4 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Heng Lin
133 papers receiving 5.5k citations
Heng Lin's Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 1.2k
- Cancer Research 796
- Molecular Biology 2.7k
- Epidemiology 958
- Nephrology 193
Countries citing papers authored by Heng Lin
This map shows the geographic impact of Heng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Lin more than expected).
Fields of papers citing papers by Heng Lin
This network shows the impact of papers produced by Heng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Lin. The network helps show where Heng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Heng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation Hit paper breakdown → | 2018 | 353 |
| 2 | 2016 | 315 | |
| 3 | 2012 | 140 | |
| 4 | 2014 | 137 | |
| 5 | 2019 | 137 | |
| 6 | 2014 | 124 | |
| 7 | 2015 | 116 | |
| 8 | 2005 | 115 | |
| 9 | 2012 | 115 | |
| 10 | 2011 | 112 | |
| 11 | 2019 | 100 | |
| 12 | 2017 | 99 | |
| 13 | 2013 | 89 | |
| 14 | 2006 | 89 | |
| 15 | 2019 | 88 | |
| 16 | 2010 | 85 | |
| 17 | 2011 | 82 | |
| 18 | 2020 | 81 | |
| 19 | 2012 | 80 | |
| 20 | 2015 | 80 |
About Heng Lin
Heng Lin is a scholar working on Molecular Biology, Immunology, Epidemiology, Cancer Research and Physiology, having authored 138 papers that have together received 5.5k indexed citations. Recurring topics across this work include interferon and immune responses (14 papers), Autophagy in Disease and Therapy (12 papers), MicroRNA in disease regulation (11 papers), Adipose Tissue and Metabolism (10 papers), Peroxisome Proliferator-Activated Receptors (10 papers), Immune Response and Inflammation (10 papers), Cancer-related molecular mechanisms research (9 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). The work is most often cited by research in Immunology (1.2k citations), Cancer Research (796 citations), Molecular Biology (2.7k citations), Epidemiology (958 citations) and Nephrology (193 citations). Heng Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ching‐Feng Cheng, Hui‐Chen Ku, Hong‐Bing Shu, Ming‐Ming Hu, Fang Hua, Hsi-Hsien Chen, Zhi Chen, Hsiao‐Fen Li, Huan Liu and Pei‐Fang Lai. Their work appears in journals such as Molecular Pharmacology, Journal of Cellular Physiology, Proceedings of the National Academy of Sciences, International Journal of Molecular Sciences and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.